Stem cells and brain organoids were the focus of a symposium during the FENS Forum of Neuroscience (7–11 July, Berlin,…
Browsing: Development and pediatrics
Scientists have identified novel genes associated with a specific form of schizophrenia, which could potentially aid diagnosis and development of treatments.
This week’s industry news round-up reveals the latest updates around spinal muscular atrophy, Parkinson’s disease and acute stroke.
A novel study reveals that the placenta could play an imperative role in schizophrenia and possibly other neurodevelopmental disorders.
Giovanni Baranello speaks to Lauren Pulling about the FIREFISH trial for spinal muscular atrophy and what the next steps of the study include.
Low levels of vasopressin may be linked to low social ability in monkeys and autism in children, indicating that the hormone could be a biomarker for autism.
A preliminary study has revealed that an investigational drug may help increase protein levels in babies with spinal muscular atrophy.
For the first time, researchers have discovered that non-gene mutations could cause rare developmental disorders of the CNS.
A recent study has reported that defects in a nuclear receptor located in the brain could be linked to autism spectrum disorders.
To mark International Women’s Day, we speak to neuroscientist and science communicator Samantha Yammine about her stem cell research and passion for communicating science to a wider audience.